We provide you with 20 years of free, institutional-grade data for KTTA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KTTA. Explore the full financial landscape of KTTA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Pasithea Therapeutics(NASDAQ:KTTA) 
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infu...
Share this website to your friends
The information provided in this report about KTTA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.